Pharmaceutics II P224PT PDF
Document Details
Uploaded by ProlificWaterfall3996
University of Tripoli
Tags
Related
Summary
This document is a summary of pharmaceutics topics. It covers preformulation and formulation studies, compatibility, kinetic rate profile, and pharmaceutical products. It discusses polymorphism, melting point depression, solubility, and dissolution rate. In addition, it discusses the various factors that affect solubility and dissolution rates and how they can be increased.
Full Transcript
# Pharmaceutics II P224PT ## Introduction - Drug substances are seldom administered in their natural or pure state, but rather as part of a **formulation** in combination with one or more non-medicinal agents that serve varied and specialized pharmaceutical functions. - Pharmaceutical aids, pharma...
# Pharmaceutics II P224PT ## Introduction - Drug substances are seldom administered in their natural or pure state, but rather as part of a **formulation** in combination with one or more non-medicinal agents that serve varied and specialized pharmaceutical functions. - Pharmaceutical aids, pharmaceutical ingredients, excipients or adjuncts result from the selective use of these non-medicinal agents. - Pharmaceutical adjuncts serve to solubilized, suspend, thicken, dilute, emulsify, stabilize, preserve, color, flavor and fashion the many and varied medicinal agents into effective and appealing pharmaceutical preparations. ## A Drug From A to Z - **Active Pharmaceutical Ingredient (API)** is the active substance responsible for the therapeutic effect. - **Preformulation studies** are done to study the physicochemical properties of the API (e.g., solubility, stability, and particle size). - **Formulation studies** are done to develop the final dosage form (e.g., tablets, capsules). - **Non-medicinal agents** (excipients/adjuncts) are added to the formulation to improve its properties (e.g., taste, stability, and dissolution). ## What are the objectives of preformulation studies ? - To establish the physicochemical parameter of new drug substances. - To establish the kinetic rate profile. - To establish physical characteristics. - To establish compatibility with the common excipients. ### Preformulation - Is a stage of development during which the physicochemical properties of drug substance are characterized (the process of optimizing a drug). - Develop a knowledge base. ## Compatibility - Materials used in formulation must be compatible, meaning that they do not interact with each other in a way that would affect the quality or efficacy of the drug product. ## Kinetic rate profile - Is the study of how the drug is absorbed, distributed, metabolized, and excreted in the body. - It helps understand how the drug behaves in the body and how it may be affected by other factors, such as food or other medications. ## Pharmaceutical Product - Is the finished drug product. - It is what is dispensed to the patient. **The proper design and formulation of a dosage form requires consideration of the physical, chemical, and biological characteristics of all of the drug substances and pharmaceutical ingredients (excipients) to be used in fabricating the product.** **The drug and pharmaceutical materials used must be COMPATIBLE and produce a drug product that is STABLE, EFFICACIOUS, PALATABLE, EASY TO ADMINISTER, and WELL TOLERATED.** ## Polymorphism - Polymorphism is the ability of a substance to exist in more than one crystalline form. - The different forms of a polymorph are generally different in stability and solubility. - The stable form is often preferred in pharmaceutical formulations due to its higher stability and lower solubility. - Amorphous form is more soluble and dissolvable than the crystalline form, but it is less stable and less preferred. - Polymorphism can also affect the bioavailability of a drug. ## Melting Point Depression - Is a characteristic of a pure substance. - A pure substance has a defined melting point or melting range. - If the substance is not pure, its melting point will be depressed. - Melting point depression can be useful for determining the purity of a substance. ## Solubility - The maximum amount of solute that dissolves in a solvent at equilibrium. - Factors that affect solubility include temperature, pressure, and the nature of the solute and solvent. - To increase solubility, the following methods can be used: - Addition of co-solvent: Water, alcohol, glycerin - Addition of complexing agent: EDTA - Chemical modification of the drug into salt or ester forms - pH adjustment: The most usable technique - Addition of surfactant: Span, tween, SLS - Particle size reduction: Small increases in solubility can be accomplished by particle reduction. ## Dissociation Constant (pka) - The extent of ionization of a drug is important because it can affect its solubility, absorption and other pharmacokinetic parameters. - Most drugs are weak organic acids or bases, meaning that they are not fully ionized in solution, and their absorption is governed to a large extent by their degree of ionization. - **Henderson Hasselbalch equation** helps to calculate the extent of ionization: - **Weak acid: pka - pH = log [(un-ionized)/(ionized)]** - **Weak base: pk₂- pH = log [(ionized)/(un-ionized)]** - The pH of the environment can affect the ionization of a drug. - **Only unionized drug molecules are absorbed across biological membranes.** ## Dissolution Rate - The time it takes for the drug to dissolve in the fluids at the absorption site. - Factors that affect dissolution rate include particle size, solubility, and the presence of other substances in the formulation. - To increase dissolution rate, the following methods can be used: - Decreasing the drug’s particle size - Increasing drug solubility in diffusion layer. - Using a highly water soluble salt of the parent substance. ## Partition Coefficient (PC or Log P) - The ratio in which a solute distributes itself between two immiscible liquids, mostly between n-octanol and water. - It is commonly used in formulation development to predict the ability of a drug to cross biological membranes, which are generally composed of lipids. - Drugs with a high partition coefficient (lipophilic) are more likely to cross biological membranes. - Drugs with a low partition coefficient (hydrophilic) are less likely to cross biological membranes. ## Macroscopic Examination - **Color:** Result of unsaturation, presence of impurities, or degradation products. - **Odor:** Result of functional groups like sulfides, sulfoxides, sulfhydryl, amines, or solvents. - **Taste:** If a taste is unacceptable, it is generally possible to circumvent this by using less soluble chemical forms, adding flavorants, or coating the solid dosage forms. ## Particle Size - Affects the following properties of drugs: - Flow properties - Content uniformity - Taste, Texture and Color. - Sedimentation rate - Dissolution rate - Absorption - Bioavailability - Stability - Particle size can be analyzed using various methods including - Sieving (screening) - Microscopy - Sedimentation - Stream scanning: Electronic microscopy ## Organoleptic Properties - These are the properties of a drug that can be perceived by the senses, such as taste, touch, smell, and appearance. - The organoleptic properties of a drug are important because they can affect its palatability, ease of administration, and patient compliance.